Search for a command to run...
Jennifer Doudna, Nobel Prize-winning biochemist, discusses the present and future of CRISPR gene editing technologies, highlighting breakthrough therapies for sickle cell disease and rare genetic disorders, while exploring potential applications in agriculture, preventive medicine, and the intersection of CRISPR with AI.
A groundbreaking AI approach using small convolutional graph neural networks and modest computational resources successfully discovered novel antibiotics that can target drug-resistant bacteria through previously unknown mechanisms.
A deep dive into the groundbreaking gene therapy treatment of baby KJ, who was born with a rare genetic disorder, highlighting the potential of personalized genetic editing to treat previously untreatable conditions.